Literature DB >> 10944600

Prognostic factors in patients with submucosal carcinoma of the oesophagus.

M Watanabe1, H Kuwano, K Araki, H Kawaguchi, H Saeki, K Kitamura, S Ohno, K Sugimachi.   

Abstract

To clarify the prognostic factors in patients with submucosal carcinoma of the oesophagus, we examined the results of surgical treatment for 78 cases over the last decade. The clinicopathological factors including age, sex, location of the tumour, length of the tumour, histological differentiation, subclassification of depth, lymphatic or blood vessel invasion, intramural metastasis and lymph node metastasis were all analysed. Then the correlation between these factors and prognosis was investigated. As a result, significant differences were observed in the survival rates between the groups regarding lymphatic vessel invasion (P = 0.0003), intramural metastasis (P = 0.0051) and lymph node metastasis (P = 0.0026). According to a multivariate analysis, intramural metastasis (P = 0.0038, relative risk 9.17), vessel invasion (P = 0.0033, relative risk 6.25) and lymph node metastasis (P = 0.0187, relative risk 3.62) were found to be independent prognostic factors. The prognosis of the patients with at least one of these factors was significantly poorer than that without. The five-year survival rate of the patients without these factors was as good as that with mucosal carcinoma of the oesophagus. Based on our findings, vessel invasion, intramural metastasis and lymph node metastasis are thus considered to be significant prognostic factors in patients with submucosal carcinoma of the oesophagus. Copyright 2000 Cancer Research Campaign.

Entities:  

Mesh:

Year:  2000        PMID: 10944600      PMCID: PMC2363521          DOI: 10.1054/bjoc.2000.1288

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  21 in total

1.  Vascular invasion of colorectal carcinoma readily visible with certain stains.

Authors:  T Inoue; M Mori; R Shimono; H Kuwano; K Sugimachi
Journal:  Dis Colon Rectum       Date:  1992-01       Impact factor: 4.585

2.  Superficial esophageal carcinoma: a clinicopathological review of 59 cases.

Authors:  H Yoshinaka; H Shimazu; T Fukumoto; M Baba
Journal:  Am J Gastroenterol       Date:  1991-10       Impact factor: 10.864

3.  Results of a nationwide study on the three-field lymph node dissection of esophageal cancer.

Authors:  K Isono; H Sato; K Nakayama
Journal:  Oncology       Date:  1991       Impact factor: 2.935

4.  Histopathological evaluation of oesophageal carcinoma: the significance of venous invasion.

Authors:  P H Theunissen; F Borchard; D C Poortvliet
Journal:  Br J Surg       Date:  1991-08       Impact factor: 6.939

5.  Prognostic significance of intramural metastasis in patients with esophageal carcinoma.

Authors:  K Takubo; K Sasajima; K Yamashita; Y Tanaka; K Fujita
Journal:  Cancer       Date:  1990-04-15       Impact factor: 6.860

Review 6.  Multimodal therapy for squamous carcinoma of the oesophagus.

Authors:  T Lehnert
Journal:  Br J Surg       Date:  1999-06       Impact factor: 6.939

Review 7.  Superficial squamous cell carcinoma of the esophagus. A report of 76 cases and review of the literature.

Authors:  W V Bogomoletz; G Molas; B Gayet; F Potet
Journal:  Am J Surg Pathol       Date:  1989-07       Impact factor: 6.394

8.  Clinicopathologic study of early stage esophageal carcinoma.

Authors:  K Sugimachi; S Ohno; H Matsuda; M Mori; H Matsuoka; H Kuwano
Journal:  Surgery       Date:  1989-06       Impact factor: 3.982

9.  Superficial carcinoma of the esophagus.

Authors:  H Shimazu; O Kobori; M Shoji; T Yokohata; Y Morioka; Y Okuyama; A Terano; A Yoshida; Y Goto
Journal:  Gastroenterol Jpn       Date:  1983-10

10.  Proposed new criteria for early carcinoma of the esophagus.

Authors:  K Sugimachi; K Kitamura; H Matsuda; M Mori; H Kuwano; H Ide
Journal:  Surg Gynecol Obstet       Date:  1991-10
View more
  6 in total

Review 1.  Surgical treatment of superficial esophageal cancer.

Authors:  Mitsuo Tachibana; Shoichi Kinugasa; Muneaki Shibakita; Yasuhito Tonomoto; Shinji Hattori; Ryoji Hyakudomi; Hiroshi Yoshimura; Dipok Kumar Dhar; Naofumi Nagasue
Journal:  Langenbecks Arch Surg       Date:  2006-07-08       Impact factor: 3.445

2.  Impact of lymph node micrometastasis in patients with pancreatic head cancer.

Authors:  Hiroshi Kurahara; Sonshin Takao; Kousei Maemura; Hiroyuki Shinchi; Shoji Natsugoe; Takashi Aikou
Journal:  World J Surg       Date:  2007-03       Impact factor: 3.352

3.  [Mucosectomy as sufficient therapy for early squamous cell].

Authors:  M Jung
Journal:  Chirurg       Date:  2005-11       Impact factor: 0.955

4.  Emerging aspects of oesophageal and gastro-oesophageal junction cancer histopathology - an update for the surgical oncologist.

Authors:  Ewen A Griffiths; Susan A Pritchard; Nicholas P Mapstone; Ian M Welch
Journal:  World J Surg Oncol       Date:  2006-11-21       Impact factor: 2.754

5.  Radiofrequency ablation for early oesophageal squamous neoplasia: outcomes form United Kingdom registry.

Authors:  Rehan J Haidry; Mohammed A Butt; Jason Dunn; Matthew Banks; Abhinav Gupta; Howard Smart; Pradeep Bhandari; Lesley Ann Smith; Robert Willert; Grant Fullarton; Morris John; Massimo Di Pietro; Ian Penman; Marco Novelli; Laurence B Lovat
Journal:  World J Gastroenterol       Date:  2013-09-28       Impact factor: 5.742

6.  Lymphovascular invasion quantification could improve risk prediction of lymph node metastases in patients with submucosal (T1b) esophageal adenocarcinoma.

Authors:  Steffi E M van de Ven; Lucia Suzuki; Annieke W Gotink; Fiebo J C Ten Kate; Daan Nieboer; Bas L A M Weusten; Lodewijk A A Brosens; Richard van Hillegersberg; Lorenza Alvarez Herrero; Cees A Seldenrijk; Alaa Alkhalaf; Freek C P Moll; Wouter Curvers; Ineke G van Lijnschoten; Thjon J Tang; Hans van der Valk; Wouter B Nagengast; Gursah Kats-Ugurlu; John T M Plukker; Martin H M G Houben; Jaap S van der Laan; Roos E Pouw; Jacques J G H M Bergman; Sybren L Meijer; Mark I van Berge Henegouwen; Bas P L Wijnhoven; Pieter J F de Jonge; Michael Doukas; Marco J Bruno; Katharina Biermann; Arjun D Koch
Journal:  United European Gastroenterol J       Date:  2021-10-05       Impact factor: 4.623

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.